Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 101

1.

Evaluation of nogalamycin-DNA complex as chemotherapeutic agent.

Chakraborty B, Nandi J, Neogy RK.

Indian J Exp Biol. 1979 Jun;17(6):595-7. No abstract available.

PMID:
500141
2.

Effect of antitumour drugs on protein synthesis.

Chowdhury K, Neogy RK.

Indian J Exp Biol. 1980 Feb;18(2):120-2. No abstract available.

PMID:
6447105
3.

Comparative biological and biochemical effects of nogalamycin and its analogs on L1210 leukemia.

Li LH, Kuentzel SL, Murch LL, Pschigoda LM, Krueger WC.

Cancer Res. 1979 Dec;39(12):4816-22. No abstract available.

4.
5.

Anthracyclines--modern tumour-inhibiting agents.

Strauss DG.

Folia Microbiol (Praha). 1978;23(2):152-61. Review. No abstract available.

PMID:
348587
6.

Comparative biological activity of nogalamycin and its analogs.

Bhuyan BK, Reusser F.

Cancer Res. 1970 Apr;30(4):984-9. No abstract available.

7.

The biochemical pharmacology of nogalamycin and its derivatives.

Li LH, Krueger WC.

Pharmacol Ther. 1991;51(2):239-55. Review.

PMID:
1838416
8.

Changes in RNA synthesis following transfer of Sarcoma 180 ascites cells from the mouse to synthetic medium.

Watson JD, Ralph RK.

Cancer Res. 1966 Nov;26(11):2362-7. No abstract available.

9.
10.

Improved antitumor activity by modification of nogalamycin.

Wiley PF.

J Nat Prod. 1979 Nov-Dec;42(6):569-82.

PMID:
541685
11.

Nucleotide sequence binding preferences of nogalamycin investigated by DNase I footprinting.

Fox KR, Waring MJ.

Biochemistry. 1986 Jul 29;25(15):4349-56.

PMID:
3019386
12.

Biochemical effects of the Vinca alkaloids. IV. Studies with vinleurosine.

Creasey WA.

Biochem Pharmacol. 1969 Jan;18(1):227-32. No abstract available.

PMID:
5780988
13.

Inhibition by phytohemagglutinin of DNA synthesis in cultured mouse lymphomas.

Dent PB.

J Natl Cancer Inst. 1971 Apr;46(4):763-73. No abstract available.

PMID:
5573768
14.

Nogalamycin analogs having improved antitumor activity.

Wiley PF, Johnson JL, Houser DJ.

J Antibiot (Tokyo). 1977 Jul;30(7):628-9. No abstract available.

15.

Effect of caffeine on macromolecular synthesis in sarcoma-180 mouse ascites cells.

Chaudhuri MM, Ghosh S.

Indian J Exp Biol. 1982 Jun;20(6):433-6. No abstract available.

PMID:
7129540
16.

Cytotoxic and mutagenic in vitro effect of 7-O-epoxyalkyl derivatives of daunomycinone. Part IX.

Sturdíková M, Fusková A, Prikrylová V, Podojil M, Fuska J.

Neoplasma. 1986;33(3):297-305.

PMID:
2426609
17.

[Antineoplastic activity of preparations of the series of phenoxazine dyes].

D'iachkovskaia RF, Parkhomenko II, Vasil'eva LS, Surkova NI, Shuppe NG, Konovalova NP, Bogdanov GN, Emanuel' NM.

Farmakol Toksikol. 1969 Jan-Feb;32(1):84-7. Russian. No abstract available.

PMID:
5770324
18.

Preferential binding of adriamycin and nogalamycin to DNase-I hypersensitive sites of Sarcoma-180 chromatin.

Panda CK, Choudhury K, Neogy RK.

Chem Biol Interact. 1986 Jan;57(1):65-72.

PMID:
3948285
19.

Preferential incorporation of sangivamycin into ribonucleic acid in Sarcoma 180 cells in vitro.

Ritch PS, Glazer RI.

Biochem Pharmacol. 1982 Jan 15;31(2):259-61. No abstract available.

PMID:
7059368
20.

Comparative effects of 1,10-phenanthroline and 1,7-phenanthroline on DNA and RNA synthesis in mouse spleen.

Chang CH, Yarbro JW.

Life Sci. 1978 Mar;22(11):1007-10. No abstract available.

PMID:
642706
Items per page

Supplemental Content

Write to the Help Desk